Health encyclopaedia - Alphabetical Topic List Gesundheits-Lexikon - Topic Alphabetische Liste
| | A | | A | | | B | | B | | | C | | C | | | D | | D | | | E | | E | | | F | | F | | | G | | G | | | H | | H | | | I | | I | | | J | | J | | | K | | K | | | L | | L | | | M | | M | |
| | N | | N | | | O | | O | | | P | | P | | | Q | | Q | | | R | | R | | | S | | S | | | T | | T | | | U | | U | | | V | | V | | | W | | W | | | X | | X | | | Y | | Y | |
References of Flu Referenzen von Grippe
1. National Institute for Clinical Excellence (NICE) Guidance on the use of zanamivir, oseltamivir and amantadine for treatment of flu . National Institute for Clinical Excellence (NICE) Leitlinien für den Einsatz von Zanamivir, Oseltamivir und Amantadin zur Behandlung von Grippe. 24 Sept, 2003 24 Sept, 2003
Further reading: Weiterführende Literatur:
National Institute for Clinical Excellence (NICE). Old guidance for zanamivir (Relenza ). London, NICE; 12 Oct, 1999. National Institute for Clinical Excellence (NICE). Alte Orientierungshilfe für Zanamivir (Relenza). London, Nizza; Oct 12, 1999.
National Institute for Clinical Excellence (NICE). Old Guidance on zanamivir (Relenza) for the treatment of influenza - patient information . National Institute for Clinical Excellence (NICE). Alte Leitlinien für Zanamivir (Relenza) für die Behandlung der Influenza - Patienten-Informationen. London: NICE; 5 Jun, 2001. London: NICE, 5 Jun, 2001.
Public Health Laboratory Service. Influenza activity information . Public Health Laboratory Service. Influenza-Aktivität. [no date] [access 2002 August] [no date] [Access 2002-August]
Department of Health. Flu and flu immunisation: use of zanamivir (brand name Relenza). London: Department of Health; 19 Feb, 2002. Department of Health. Grippe und Grippe Immunisierung: Einsatz von Zanamivir (Relenza Markenname). London: Department of Health; 19 Feb, 2002.
NHS Direct is not responsible for the content of external web sites. NHS Direct ist nicht verantwortlich für die Inhalte externer Internetseiten.









